Please login to the form below

Blue Latitude Health joins Fishawack Group of Companies

Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.

Blue Latitude Health is delighted to announce that we have joined the Fishawack Group of Companies as part of our international growth plans.

The partnership comes after an outstanding year in which we welcomed new clients, moved to new offices in Barbican, Central London, and have expanded our New York team.

“Since we set up the company in 2003 our growth has been strong and organic. In the last year alone, we have seen double digit growth in both the UK and US”, said Martin Brass, MD and Co-founder of Blue Latitude Health.

“To enable us to continue to grow and provide existing and future clients with a stronger offering, we needed to find a partner who shared both our values and matched our ambition. We believe we have found this partner in Fishawack.’’

Fred Bassett, Head of Strategy and Co-founder of Blue Latitude Health, added, “We are thrilled to join an organisation with the global scale and extended services in medical and scientific communications that Fishawack offers. Our strategic and commercial focus will complement Fishawack’s scientific and medical foundations and allow us to expand our reach, particularly in the US, while deepening our client relationships.”

Fishawack is one of the world’s leading independent medical communications and medical marketing agencies, with offices in London, Oxford, Knutsford, Brighton, San Diego, Philadelphia, and India. The organisation has more than 400 members of staff, including more than 120 medical experts and writers, 90% of whom have PhDs, PharmDs or MDs. The depth and breadth of its scientific and medical expertise, coupled with its unique physician-partnered consulting model, truly delivers our clients an enhanced offering at all stages of the product lifecycle.

“Just like Blue Latitude Health, Fishawack work with some of the biggest global pharmaceutical, biotech and healthcare innovators,’’ added Simon Young, Commerical Director.

Although we have some clients in common with Fishawack, we also have clients that are unique to each company and therefore there is great potential to offer both existing and new clients an extended and unbeatable service. This new partnership compliments Fishawack’s vision to expand its commercial capabilities by incorporating our strong foundation of strategic and user experience skills into the wider group.

“Blue Latitude Health have an excellent reputation in the industry and are known for the quality of their work’’, explained Oliver Dennis, Chief Executive Officer at Fishawack Group of Companies. “We were actively looking for a consultancy who could bring strategic and customer experience expertise to our portfolio. We are delighted to be able to bring these capabilities to our existing and future clients.”

The medical organisation is also focused on growing its creative capability and is keen to harness our end-to-end creative skills, as one of the world’s first creative marketing consultancies, to its repertoire.

Chris Field, Head of Creative Services at Blue Latitude Health, explained: “Our clients will benefit by having access to a larger and more diverse creative team. So long as it provides our clients commercial impact, we are un-restricted in our ability to execute – from conceptual through to digital, motion graphics, and event logistics, all supported by an expanded range of therapy area experiences.”

We’re excited for this new chapter and the opportunities it brings. For more information about Blue Latitude Health and our recent partnership, please contact martin.brass@bluelatitude.com

12th December 2018

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health
Great creative is effective creative. And effective creative is affective creative
Our creative approach at Fishawack Health is Affective Creativity. Creative crafted to make deep, motivating connections with our target audience. We tap into psychology and combine that with creative craft and expertise and to deliver powerful, engaging work on a conscious as well as a subconscious level.
Blue Latitude Health